These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of crystals in kidneys of AIDS patients treated with foscarnet. Maurice-Estepa L; Daudon M; Katlama C; Jouanneau C; Sazdovitch V; Lacour B; Beaufils H Am J Kidney Dis; 1998 Sep; 32(3):392-400. PubMed ID: 9740154 [TBL] [Abstract][Full Text] [Related]
4. Convenient twice daily foscarnet in induction therapy of AIDS-associated cytomegalovirus retinitis. The Foscarnet Italian Study Group. Carosi G; Castelli F; Lernestedt JO; Antoniazzi E; Gerna G AIDS; 1997 Feb; 11(2):258-60. PubMed ID: 9030380 [No Abstract] [Full Text] [Related]
5. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome]. Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306 [TBL] [Abstract][Full Text] [Related]
6. Phosphonoformate for CMV retinitis in AIDS. Colucciello M Am J Med; 1995 Mar; 98(3):317-8. PubMed ID: 7872354 [No Abstract] [Full Text] [Related]
8. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522 [TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Balfour HH Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708 [TBL] [Abstract][Full Text] [Related]
11. Transient foscarnet-induced hypercalcaemia. Barba R; Gómez-Rodrigo J; Marco J; Espejo M; Mena D AIDS; 1998 Oct; 12(14):1930-1. PubMed ID: 9792397 [No Abstract] [Full Text] [Related]
12. Efficacy of intravitreal foscarnet in a patient with AIDS. Lieberman RM; Orellana J; Melton RC N Engl J Med; 1994 Mar; 330(12):868-9. PubMed ID: 8114855 [No Abstract] [Full Text] [Related]
13. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
14. Foscarnet or ganciclovir for treatment of AIDS and CMV retinitis. Moyle G; Gazzard BG Am J Med; 1995 Mar; 98(3):319-20. PubMed ID: 7872356 [No Abstract] [Full Text] [Related]
15. Support for new foscarnet indication for AIDS-related CMV retinitis is mixed. AIDS Patient Care STDS; 1997 Oct; 11(5):377. PubMed ID: 11361828 [No Abstract] [Full Text] [Related]
16. Current management of cytomegalovirus disease in patients with AIDS. Jacobson MA AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543 [TBL] [Abstract][Full Text] [Related]
17. New treatment options for CMV retinitis in AIDS. Lalezari JP Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896 [No Abstract] [Full Text] [Related]
18. Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection. Justrabo E; Zanetta G; Martin L; Assem M; Mousson C; Maurice-Estepa L; Rifle G; Tanter Y Histopathology; 1999 Apr; 34(4):365-9. PubMed ID: 10231404 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis: new developments in prophylaxis and therapy. Jacobson MA AIDS Clin Rev; 1997-1998; ():249-69. PubMed ID: 9305451 [No Abstract] [Full Text] [Related]
20. Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. Mueller AJ; Jacobson MA; Hurwitz S; Chuang EL; Friedberg DN; Haidt SJ; Heinemann MH; Jabs DA; Kaplan HJ; Freeman WR AIDS; 1997 Mar; 11(3):397-9. PubMed ID: 9147441 [No Abstract] [Full Text] [Related] [Next] [New Search]